CWA CA - Torrent Pharmaceuticals Executive CFO
| TORNTPHARM | 3,324 121.25 3.79% |
CFO
CWA CA is Executive CFO of Torrent Pharmaceuticals Limited
| Age | 52 |
| Address | Torrent House, Ahmedabad, India, 380009 |
| Phone | 91 79 2659 9000 |
| Web | https://www.torrentpharma.com |
Torrent Pharmaceuticals Management Efficiency
The company has return on total asset (ROA) of 0.1171 % which means that it generated a profit of $0.1171 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.2537 %, meaning that it generated $0.2537 on every $100 dollars invested by stockholders. Torrent Pharmaceuticals' management efficiency ratios could be used to measure how well Torrent Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. As of now, Torrent Pharmaceuticals' Net Tangible Assets are increasing as compared to previous years.Similar Executives
| Found 2 records | CFO Age | ||
| Sachin Gupta | LT Foods Limited | 45 | |
| Rajeshkumar Doraiswamy | Salzer Electronics Limited | 53 | |
Management Performance
| Return On Equity | 0.25 | ||||
| Return On Asset | 0.12 |
Torrent Pharmaceuticals Leadership Team
Elected by the shareholders, the Torrent Pharmaceuticals' board of directors comprises two types of representatives: Torrent Pharmaceuticals inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Torrent. The board's role is to monitor Torrent Pharmaceuticals' management team and ensure that shareholders' interests are well served. Torrent Pharmaceuticals' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Torrent Pharmaceuticals' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Jaydip Bhatt, Vice Resource | ||
| Sanjay Gupta, President USA | ||
| Samir Mehta, Ex MD | ||
| Aman Mehta, WholeTime Director | ||
| Kaushal CA, Vice Finance | ||
| Chintan Trivedi, Company Officer | ||
| MMS BE, VP Projects | ||
| Chandrashekhar CA, VP Procurement | ||
| Ashish MPharm, Executive Director | ||
| CWA CA, Executive CFO | ||
| MPha BPharm, Vice Works | ||
| Abdullah Abri, Chief Officer |
Torrent Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Torrent Pharmaceuticals a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.25 | ||||
| Return On Asset | 0.12 | ||||
| Profit Margin | 0.16 % | ||||
| Operating Margin | 0.26 % | ||||
| Current Valuation | 1.14 T | ||||
| Shares Outstanding | 338.44 M | ||||
| Shares Owned By Insiders | 69.74 % | ||||
| Shares Owned By Institutions | 14.09 % | ||||
| Price To Book | 14.99 X | ||||
| Price To Sales | 10.02 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Torrent Stock
Torrent Pharmaceuticals financial ratios help investors to determine whether Torrent Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Torrent with respect to the benefits of owning Torrent Pharmaceuticals security.